Viridian Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
13 Sep 24 | Buy€27,057,000 | Fairmount Funds Management LLC | Company | 1,600,000 | €16.91 | |
22 Jan 24 | Buy€9,182,991 | Fairmount Funds Management LLC | Company | 476,190 | €19.28 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 35,074 | 0.0459% |
General Public | 4,803,833 | 6.29% |
VC/PE Firms | 7,806,520 | 10.2% |
Institutions | 63,711,093 | 83.4% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 74.8%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
9,573,348 | €181.7m | 1.68% | 0.01% | |||
4,773,622 | €90.6m | 25.2% | no data | |||
3,923,849 | €74.5m | 13.5% | 2.27% | |||
3,882,671 | €73.7m | 0% | 3.54% | |||
3,445,813 | €65.4m | 86.7% | 5.29% | |||
3,345,731 | €63.5m | 3.45% | no data | |||
3,307,945 | €62.8m | 22.9% | 1.28% | |||
2,896,349 | €55.0m | -42.4% | 2.14% | |||
2,772,379 | €52.6m | -38.2% | no data | |||
2,528,032 | €48.0m | 30.7% | 3.37% | |||
2,000,000 | €38.0m | 81.8% | 0.03% | |||
1,998,192 | €37.9m | 16% | 0.01% | |||
1,750,000 | €33.2m | 1,210% | 3.46% | |||
1,678,207 | €31.8m | 0% | 2.73% | |||
1,631,828 | €31.0m | -55.4% | 0.78% | |||
1,411,360 | €26.8m | 21.2% | no data | |||
1,392,925 | €26.4m | 101% | 2.64% | |||
1,022,104 | €19.4m | -6.69% | 0.02% | |||
955,269 | €18.1m | 105% | 0.01% | |||
948,130 | €18.0m | 0% | 2.65% | |||
889,198 | €16.9m | 0% | 0.07% | |||
749,804 | €14.2m | 168% | 0.04% | |||
736,595 | €14.0m | 0% | 3.4% | |||
620,000 | €11.8m | 0% | 2.09% | |||
605,816 | €11.5m | 0% | 0.19% |